UBL4A and familial pancreatic carcinoma: Additionally, immunohistochemical results showed that the UBL4A level was positively correlated with the expression of LAMP1, LC3B, p62, and E-cadherin and negatively correlated with CTSB, vimentin, and N-cadherin in pancreatic cancer patients (Fig. 8i).